African-Americans Shown to Benefit from Single Pill for Blood Pressure, Cholesterol

| Feb 20, 2008

A Wayne State University Health Clinic study has shown that a single pill containing both a blood pressure-lowering drug and a cholesterol-lowering drug may be of particular benefit for African Americans.

Researchers sponsored by Pfizer studied the effects of Pfizer's Caduet, a single pill that contains the drugs amlodipine and atorvastatin, used to lower high blood pressure and high cholesterol, respectively.

For as yet unestablished reasons, it is harder for African Americans than for the general U.S. population to bring blood pressure and "bad" LDL cholesterol under control. By providing a one-pill solution, researchers hoped to see a substantial improvement in control rates among African Americans.

They did. At the start of the study, which involved 499 African Americans with uncontrolled hypertension and elevated cholesterol or triglycerides, fewer than 1 percent had achieved control of those conditions. However, after receiving Caduet in eight different dosages, which were increased as needed, 48.3 percent of participants had achieved control over both conditions by week 20.

Patients tolerated the pill well. The most common treatment-related complications were peripheral swelling (3.4 percent), headache (2.2 percent), muscle pain (2.2 percent) and constipation (2.0 percent). Researchers say none of those reactions was considered severe.

Source: MedlinePlus; Mayo Clinic Proceedings

Click Here To View Or Post Comments

Categories: Heart Care & Heart Disease, Medications, Professional Issues


Diabetes Health Professional
Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.